• 

  Addition of gemcitabine to paclitaxel, epirubicin, and cyclophosphamide adjuvant chemotherapy for women with early-stage breast cancer (tAnGo): Final 10-year follow-up of an open-label, randomised, phase 3 trial 

  Earl, HM; Hiller, L; Howard, HC; Dunn, JA; Young, J; Bowden, SJ; McDermaid, MWaterhouse, AKWilson, GAgrawal, RO'Reilly, SBowman, ARitchie, DMGoodman, AHickish, TMcAdam, KCameron, DDodwell, DRea, DWCaldas, CProvenzano, EAbraham, JECanney, PCrown, JPKennedy, MJColeman, RLeonard, RCCarmichael, JAWardley, AMPoole, CJ et al. (Elsevier, 2017-01-01)
• 

  Highly Conformal Craniospinal Radiotherapy Techniques Can Underdose the Cranial Clinical Target Volume if Leptomeningeal Extension through Skull Base Exit Foramina is not Contoured 

  Noble, DJ; Ajithkumar, T; Lambert, J; Gleeson, I; Williams, MV; Jefferies, SJ (Elsevier, 2016-12-22)

  $\textbf{AIMS}$: Craniospinal irradiation (CSI) remains a crucial treatment for patients with medulloblastoma. There is uncertainty about how to manage meningeal surfaces and cerebrospinal fluid (CSF) that follows cranial ...
• 

  Fast imaging employing steady-state acquisition (FIESTA) MRI to investigate cerebrospinal fluid (CSF) within dural reflections of posterior fossa cranial nerves 

  Noble, DJ; Scoffings, D; Ajithkumar, T; Williams, MV; Jefferies, SJ (British Institute of Radiology, 2016-09-29)

  $\textbf{OBJECTIVE}$: There is no consensus approach to covering skull base meningeal reflections-and cerebrospinal fluid (CSF) therein-of the posterior fossa cranial nerves (CNs VII-XII) when planning radiotherapy (RT) ...
• 

  Phase 1 Dose-Escalation Study of Pegylated Arginine Deiminase, Cisplatin, and Pemetrexed in Patients With Argininosuccinate Synthetase 1-Deficient Thoracic Cancers 

  Beddowes, E; Spicer, J; Chan, PY; Khadeir, R; Corbacho, JG; Repana, D; Steele, JPSchmid, PSzyszko, TCook, GDiaz, MFeng, XJohnston, AThomson, JSheaff, MWu, B-WBomalaski, JPacey, SSzlosarek, PW et al.

  $\textbf{Purpose}$ Pegylated arginine deiminase (ADI-PEG 20) depletes essential amino acid levels in argininosuccinate synthetase 1 (ASS1) –negative tumors by converting arginine to citrulline and ammonia. The main aim ...

View more